David Michael Clark insider trades
Open-market stock purchases and sales by David Michael Clark, Chief People Officer at Amicus Therapeutics, Inc, from SEC Form 4 filings since Oct 9, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $3.2M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.1M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $774K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $873K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.3M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.3M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.2M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.2M |
| Jan 3, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $264K |
| Jan 2, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $76.8K |
| Dec 19, 2025 | FOLD Amicus Therapeutics, Inc | Sold | $363K |
| Dec 15, 2025 | FOLD Amicus Therapeutics, Inc | Sold | $282K |
| Nov 24, 2025 | FOLD Amicus Therapeutics, Inc | Sold | $259K |
| Nov 4, 2025 | FOLD Amicus Therapeutics, Inc | Sold | $244K |
Companies traded
- FOLD Amicus Therapeutics, Inc: 12 sales, last Apr 27, 2026
Get free alerts when David Michael Clark files a new trade →